Neurotrophic keratopathy: Clinical presentation and effects of cenegermin

Neurotrophic keratopathy: Clinical presentation and effects of cenegermin

Purpose: To report on 4 patients (3 adults, 1 child) with neurotrophic keratopathy (NK) treated with cenegermin 20 μg/ml (Oxervate®), a recombinant human nerve growth factor (rhNGF), which was authorized by the European Medicines Agency for the treatment of neurotrophic keratopathy stage 2 and stage...

Full description

Bibliographic Details
Main Authors:	Julia Bing Bu, Adrian Gericke, Norbert Pfeiffer, Joanna Wasielica-Poslednik
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	American Journal of Ophthalmology Case Reports
Subjects:	Neurotrophic keratopathy Nerve growth factor Cenegermin
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993622002341

Similar Items

Resolution of a neurotrophic keratopathy associated hypopyon with cenegermin
by: Nick Zambino, et al.
Published: (2021-09-01)

Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up
by: Salvador García-Delpech, et al.
Published: (2022-08-01)

Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO)
by: Pedram Hamrah, et al.
Published: (2024-01-01)

Effect of recombinant human nerve growth factor treatment on corneal nerve regeneration in patients with neurotrophic keratopathy
by: Ana Balbuena-Pareja, et al.
Published: (2023-10-01)

Neurotrophic Keratopathy in Systemic Diseases: A Case Series on Patients Treated With rh-NGF
by: Alessandro Meduri, et al.
Published: (2022-05-01)

Role of Topical Cenegermin in Management of a Cornea Transplant in a Functionally Monocular Patient with Neurotrophic Keratitis and Facial Nerve Palsy: A Case Report
by: Pocobelli A, et al.
Published: (2020-11-01)

Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment
by: Alice T. Epitropoulos, et al.
Published: (2022-09-01)

Topical cenegermin associated ocular surface and contact lens drug precipitate deposit formation
by: Craig A. White, et al.
Published: (2022-09-01)

Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
by: Francesco Buonfiglio, et al.
Published: (2024-01-01)

Neurotrophic keratopathy: current challenges and future prospects
by: Erin NaPier, et al.
Published: (2022-12-01)

Pathogenetic treatment for neurotrophic keratopathy
by: T. B. Gaidamaka, et al.
Published: (2018-04-01)

Trigeminal trophic syndrome and neurotrophic keratopathy following stroke
by: Ipek Gungor-Dogan, et al.
Published: (2020-01-01)

A New Treatment for Recalcitrant Neurotrophic Keratopathy of Ocular Graft-Versus-Host Disease with Virus Infection
by: Yi Qu, et al.
Published: (2023-12-01)

Aberrant Corneal Homeostasis in Neurosurgery-Induced Neurotrophic Keratopathy
by: Shimpei Oba, et al.
Published: (2022-06-01)

Chitosan-based thermosensitive hydrogel with long-term release of murine nerve growth factor for neurotrophic keratopathy
by: Jie Wu, et al.
Published: (2024-01-01)

Use of Tachosil® as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
by: Miriam Rahhal-Ortuño, et al.
Published: (2019-01-01)

Minimally invasive corneal neurotization for neurotrophic keratopathy: The potential effect of age, denervation chronicity and lesion location
by: Darren S.J. Ting, et al.
Published: (2023-03-01)

Ipsilateral supraorbital nerve transfer in a case of recalcitrant neurotrophic keratopathy with an intact ipsilateral frontal nerve: A novel surgical technique
by: Frances Jacinto, et al.
Published: (2016-12-01)

Bilateral corneal perforation caused by neurotrophic keratopathy associated with leprosy: a case report
by: Satoshi Iraha, et al.
Published: (2022-01-01)

Minimally invasive, indirect corneal neurotization using an ipsilateral sural nerve graft for early neurotrophic keratopathy
by: Brendon W.H. Lee, et al.
Published: (2022-09-01)

Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?
by: Mohammad Al Hariri, et al.
Published: (2024-01-01)

Corneal perforation associated with ocular rosacea and neurotrophic keratopathy
by: Mariana Lopez-Martinez, et al.
Published: (2020-01-01)

Sphingomonas paucimobilis keratitis in a patient with neurotrophic keratopathy and severe neurosensory hypoacusis: Treatment with penetrating keratoplasty and amniotic membrane grafting
by: Manuel Roca, et al.
Published: (2018-01-01)

Topical Insulin in Neurotrophic Keratopathy: A Review of Current Understanding of the Mechanism of Action and Therapeutic Approach
by: Marcin Jaworski, et al.
Published: (2023-12-01)

The Role of Hi-Tech Devices in Assessment of Corneal Healing in Patients with Neurotrophic Keratopathy
by: Leandro Inferrera, et al.
Published: (2022-03-01)

A corneal ring ulcer
by: Khaled Alhajraf, et al.
Published: (2020-12-01)

Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: Case report and literature review
by: Giuseppe Giannaccare, et al.
Published: (2022-06-01)

Neurotrophic Keratitis Due to Congenital Corneal Anesthesia with Deafness, Hypotonia, Intellectual Disability, Face Abnormality and Metabolic Disorder: A New Syndrome?
by: Arvydas Gelzinis, et al.
Published: (2022-05-01)

Diabetic Corneal Neuropathy
by: Hassan Mansoor, et al.
Published: (2020-12-01)

Emergency management: exposure keratopathy
by: Wanjiku Mathenge
Published: (2018-11-01)

Congenital Hypoplastic Trigeminal Nerve Revealed by Manifestation of Corneal Disorders Likely Caused by Neural Factor Deficiency
by: Naoyuki Morishige, et al.
Published: (2014-06-01)

0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
by: Gabriel Sosne, et al.
Published: (2022-12-01)

Unilateral Idiopathic Lipid Crystalline Keratopathy: A Clinicopathological Report
by: Hamidreza Hasani, et al.
Published: (2021-05-01)

Neurotization of the human cornea – A comprehensive review and an interim report
by: Anubha Rathi, et al.
Published: (2022-01-01)

Raloxifene induced keratopathy: A case report
by: Ji Min Park, et al.
Published: (2022-09-01)

Observational study of cenegermin for the treatment of limbal stem cell deficiency associated with neurotrophic keratopathy
by: Alejandro Arboleda, et al.
Published: (2022-11-01)

Advances in the application of confocal microscopy to keratopathy
by: Qiao Zheng, et al.
Published: (2019-09-01)

Effects of Diabetes Mellitus on Corneal Immune Cell Activation and the Development of Keratopathy
by: Pier Luigi Surico, et al.
Published: (2024-03-01)

Atypical presentation of acanthamoeba keratitis resembling central toxic keratopathy
by: Mathew S. Ward, et al.
Published: (2022-03-01)

Neurotrophic factors and corneal nerve regeneration
by: Marta Sacchetti, et al.
Published: (2017-01-01)